Discovery and development of COVID-19 vaccines and therapeutics: nonclinical perspectives
Description
The development and regulatory review of BNT162b2, a COVID-19 vaccine, and Paxlovid^(TM) (nirmatrelvir tablets/ritonavir tablets), a COVID-19 therapeutic, are benchmarks for accelerated innovation during a global pandemic. Rapid choice of the SARS
